Market Tracker

07/21 5:16pm ET

Novavax Inc (NASDAQ:NVAX)

1.48
Delayed Data
As of Jul 21
 -0.03 / -1.99%
Today’s Change
0.73
Today|||52-Week Range
8.49
+17.46%
Year-to-Date

Today’s Trading

Previous close1.51
Today’s open1.53
Day’s range1.45 - 1.54
Volume7,161,241
Average volume (3 months)6,402,921
Market cap$418.3M
Dividend yield--
Data as of 3:59pm ET, 07/21/2017

Growth & Valuation

Earnings growth (last year)-71.67%
Earnings growth (this year)+40.66%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-57.65%
P/E ratioNM
Price/Sales22.22
Price/Book--

Competitors

 Today’s
change
Today’s
% change
JNCEJounce Therapeutics ...+0.02+0.15%
BCRXBioCryst Pharmaceuti...-0.16-2.87%
NSTGNanoString Technolog...-0.11-0.69%
AGENAgenus Inc+0.02+0.40%
Data as of 4:00pm ET, 07/21/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$15.4M
Annual profit (last year)-$280.0M
Net profit margin-1,823.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
Senior VP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts